Roth Capital Sets $42 Price Target for Alico (NASDAQ:ALCO)
Gerry Sweeney from Roth Capital set a price target of $42 for Alico, Inc. (NASDAQ:ALCO) on November 26, 2025. This target suggests a potential increase of approximately 22.8% from the stock's price of $34.20 at that time.
Investment firms have increased their stakes in Alico. Accordant Advisory Group Inc boosted its investment by 14.4% during the second quarter, now holding 50,202 shares. This investment is valued at $1.6 million USD and represents 1.2% of Accordant's portfolio. Other firms, including Peapod Lane Capital LLC and Towerview LLC, also adjusted their positions, indicating broader interest in Alico's potential.
Peapod Lane Capital LLC increased its holdings by 0.3%, bringing its total to 131,265 shares, valued at $4.3 million USD. Towerview LLC boosted its holdings by 8.7%, now possessing 125,000 shares worth $4.1 million USD.
As of December 1, 2025, Alico's stock traded at $34.46 on the NASDAQ exchange, reflecting an increase of approximately 3.55% or $1.18 for the day. The stock has fluctuated between a low of $33.49 and a high of $34.74 today. Over the past year, ALCO has ranged from a low of $24.76 to a high of $35.90. The company, which focuses on agribusiness, citrus production, and land management, has a market capitalization of approximately $266 million USD, with a trading volume of 36,229 shares.
Related Blogs:
Alico, Inc. (ALCO) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.